These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21621597)

  • 1. Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery.
    Xu J; Ganesh S; Amiji M
    Int J Pharm; 2012 May; 427(1):21-34. PubMed ID: 21621597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract.
    Bhavsar MD; Amiji MM
    AAPS PharmSciTech; 2008; 9(1):288-94. PubMed ID: 18446494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract.
    Kriegel C; Attarwala H; Amiji M
    Adv Drug Deliv Rev; 2013 Jun; 65(6):891-901. PubMed ID: 23220324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic gene delivery and transfection in human pancreatic cancer cells using epidermal growth factor receptor-targeted gelatin nanoparticles.
    Xu J; Amiji M
    J Vis Exp; 2012 Jan; (59):e3612. PubMed ID: 22231028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).
    Bhavsar MD; Amiji MM
    J Control Release; 2007 Jun; 119(3):339-48. PubMed ID: 17475358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease.
    Kriegel C; Amiji M
    J Control Release; 2011 Feb; 150(1):77-86. PubMed ID: 20959130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cells.
    Magadala P; Amiji M
    AAPS J; 2008 Dec; 10(4):565-76. PubMed ID: 19034673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
    Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
    Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and Biodistribution Analysis of Small Interference RNA for Silencing Tissue Transglutaminase-2 in Celiac Disease After Oral Administration in Mice Using Gelatin-Based Multicompartmental Delivery Systems.
    Attarwala HZ; Suri K; Amiji MM
    Bioelectricity; 2020 Jun; 2(2):167-174. PubMed ID: 34471844
    [No Abstract]   [Full Text] [Related]  

  • 10. Biocompatible gelatin nanoparticles for tumor-targeted delivery of polymerized siRNA in tumor-bearing mice.
    Lee SJ; Yhee JY; Kim SH; Kwon IC; Kim K
    J Control Release; 2013 Nov; 172(1):358-366. PubMed ID: 24036198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies.
    Kaul G; Amiji M
    Pharm Res; 2005 Jun; 22(6):951-61. PubMed ID: 15948039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarrier Mediated siRNA Delivery Targeting Stem Cell Differentiation.
    Fernandes F; Kotharkar P; Chakravorty A; Kowshik M; Talukdar I
    Curr Stem Cell Res Ther; 2020; 15(2):155-172. PubMed ID: 31789134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is nanotechnology a boon for oral drug delivery?
    Agrawal U; Sharma R; Gupta M; Vyas SP
    Drug Discov Today; 2014 Oct; 19(10):1530-46. PubMed ID: 24786464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of non-viral vector for cancer gene therapy.
    Hattori Y
    Yakugaku Zasshi; 2010 Jul; 130(7):917-23. PubMed ID: 20606371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review.
    Varshosaz J; Taymouri S
    Curr Pharm Des; 2015; 21(29):4310-28. PubMed ID: 26323421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-based targeted polymeric nanoparticles for siRNA delivery.
    Hussein WM; Cheong YS; Liu C; Liu G; Begum AA; Attallah MA; Moyle PM; Torchilin VP; Smith R; Toth I
    Nanotechnology; 2019 Oct; 30(41):415604. PubMed ID: 31295734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethylenimine as a promising vector for targeted siRNA delivery.
    Nimesh S
    Curr Clin Pharmacol; 2012 May; 7(2):121-30. PubMed ID: 22432843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research progress on siRNA delivery with nonviral carriers.
    Gao Y; Liu XL; Li XR
    Int J Nanomedicine; 2011; 6():1017-25. PubMed ID: 21720513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic polyspermine imidazole-4, 5-amide as an efficient and cytotoxicity-free gene delivery system.
    Duan SY; Ge XM; Lu N; Wu F; Yuan W; Jin T
    Int J Nanomedicine; 2012; 7():3813-22. PubMed ID: 22888236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.